LCID vs SPRO · rev $687.8M vs P/E 9.6, rev $258.0K
Lucid Group Inc (LCID) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Peter Rawlinson.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported LCID revenue for 2026-06-30 was $687.8M. Net income was -$2.06B. LCID currently screens at market cap $2.04B.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
LCID currently screens at market cap $2.04B. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the LCID and SPRO stock pages for the full models.
Not investment advice.